Chart: Biotech Stocks - Week Over Week Price & Volume Breakouts

by: SA Editors

● Amylin Pharmaceuticals (AMLN) announced on March 30th that it had raised net proceeds of $441.4mm in a public offering of 10mm shares. Forbes reported on March 30th that Amlyn's price target was raised to $60 (from $50) by Jim Reddoch, a research analyst for Friedman, Billings, Ramsey.

● Amgen (AMGN) and Abgenix (ABGX) announced on March 30th that they submitted their cancer drug panitumumbab for approval by the FDA. On March 29th, Abgenix shareholders approved the sale of Abgenix to Amgen.

New 52 Week Highs (Week Ending March 31, 2006): ABGX ($22.50), AMLN ($49.08), CELG ($44.22)


Data in table version -- click on a ticker for opinion and analysis of the company:

Price Volume
Ticker Company Change Change
ABGX Abgenix Inc. 0.6%
-18.7%
AFFX Affymetrix Inc. 3.4%
-2.6%
ALXN Alexion Pharmaceuticals Inc. 1.4%
-29.7%
AMGN Amgen Inc. -0.6%
21.1%
AMLN Amylin Pharmaceuticals Inc. 4.6%
79.7%
BIIB Biogen Idec Inc. 1.4%
-16.0%
BMRN BioMarin Pharmaceutical Inc. 0.8%
-46.3%
BSTE Biosite Incorporated 1.2%
-31.3%
CELG Celgene Corporation 5.5%
-3.8%
DNA Genentech Inc. -0.5%
-41.1%
ELN Elan Corp. plc 4.0%
-40.7%
GILD Gilead Sciences Inc. -0.2%
-4.1%
GPRO Gen-Probe Inc. 1.5%
-46.2%
IMCL Imclone Systems Inc. -0.7%
-15.4%
INCY Incyte Corp. 0.2%
-32.8%
ISTA ISTA Pharmaceuticals Inc. -7.0%
41.3%
KOSP KOS Pharmaceuticals Inc. -2.2%
-46.0%
MEDI MedImmune Inc. 0.9%
36.0%
NABI Nabi Biopharmaceuticals -0.9%
-70.5%
NBIX Neurocrine Biosciences Inc. -5.8%
6.1%
ONXX Onyx Pharmaceuticals Inc. -0.8%
-38.4%
PGNX Progenics Pharmaceuticals Inc. -3.7%
-48.9%
PHRM Pharmion Corp. 1.9%
-16.4%
TELK Telik Inc. 1.3%
-48.9%
VRTX Vertex Pharmaceuticals Inc. 0.4%
-16.6%

Data: Capital IQ

Related:

  1. Most recent opinion and analysis of Biotech stocks
  2. Full transcripts of recent conference calls in the Biotech sector
  3. Add the Biotech Stock Blog to your My Yahoo! page